Research funder · United States
Michael J. Fox Foundation for Parkinson's Research
Non-profit organization in the USA
- Grants since 2016
- 1 275
- Awarded, last 5 years (where amounts are published)
- —
- Funded works, last 5 years
- 3 085
- Funded works, all time
- 6 716
Grants
2023 · research · Research Grant
Establishing the South Carolina Parkinson’s Disease Registry
Gonzalo J. Revuelta · Murray Center For Research In Parkinson's Disease And Related Disorders
2023 · research · Research Grant
Subtyping Parkinson’s Disease Using Genetic and Intestinal Inflammation Biomarkers
Inga Peter · Icahn School of Medicine at Mount Sinai
2023 · research · ASAP
(SUPPLEMENT) Examining How Genes and Gut Bacteria Cooperate to Cause Parkinson’s Disease
Anthony Schapira · University College London
2023 · research · Translational Pipeline Program
Using Cellular Approaches to Deep Brain Stimulation to Revert Gait Disorders
Nadine Katrin Gut · Rutgers, The State University of New Jersey
2023 · research · Research Grant
Non-Invasive Method for Recovering Protein Biomarkers in Parkinson’s Disease
Nora Vanegas-Arroyave · Baylor College Of Medicine Parkinson’s Disease Center And Movement Disorders Clinic
2023 · research · Accelerating Biological Understanding and Therapeutic Translation for Parkinson’s Disease Program
Using a Virally Encoded, Single-chain Antibody as a Noninvasive Gene Therapy for Parkinson’s Disease
Martin Lévesque · Department Of Psychiatry And Neurosciences, Université Laval, And Cervo Brain Research Centre
2023 · research · Research Grant
Leveraging Gene Expression Data to Redefine Parkinson’s Disease and the Pathways Driving Disease in Different Individuals
Mina Ryten · University College London
2023 · research · Accelerating Biological Understanding and Therapeutic Translation for Parkinson’s Disease Program
Investigating the Molecular Basis of Neurodegeneration in GBA-associated Parkinson's Disease
Monther Abu-Remaileh · Stanford University
2023 · research · Accelerating Biological Understanding and Therapeutic Translation for Parkinson’s Disease Program
Analysis of Skin Biopsies from the Systemic Synuclein Sampling Study by Alpha-synuclein Seed Amplification Assay
Brit Mollenhauer · Universitätsmedizin Göttingen
2023 · research · Accelerating Biological Understanding and Therapeutic Translation for Parkinson’s Disease Program
Targeting the Dopamine D1 Receptor for a Treatment of Parkinson’s Disease with Minimal L-DOPA-induced Dyskinesia
Lawrence Barak · Duke University
2023 · research · Research Grant
Development of a Protein Biomarker Panel to Measure Parkinson’s Disease Heterogeneity and Progression
James Langdon Eubanks · Octave Bioscience
2023 · research · Accelerating Biological Understanding and Therapeutic Translation for Parkinson’s Disease Program
Structure and Mechanism of PINK1-TOM Supercomplex Formation
Mohamed A. Eldeeb · McGill University
2023 · research · Research Grant
A Novel Preclinical Candidate for Reducing Alpha-synuclein Aggregation in Parkinson’s Disease
Paul Gregor · Gismo Therapeutics, Inc.
2023 · research · Translational Pipeline Program
Targeting Activation of Microglia and Recruitment of Inflammatory Monocytes as a Therapeutic Approach for Parkinson’s Disease
Vineet Gupta · The University of Texas Medical Branch at Galveston
2023 · research · Lysosomal Biomarkers Program
Development of Autophagy-lysosome Biomarkers for Parkinson’s Disease Using Stem Cell-derived Neurons and Biofluids
Zhenyu Yue · Icahn School of Medicine at Mount Sinai
2023 · research · Research Grant
Allogeneic Bone marrow-derived Mesenchymal Stem Cells as a Disease-modifying Therapy for Idiopathic Parkinson’s Disease: Phase 2a Double-Blind, Randomized Controlled Trial
Mya Caryn Schiess · The University of Texas Health Science Center at Houston
2023 · research · Research Grant
Evaluating a Gene Therapy that Restores Mitochondrial Function as a Treatment for Parkinson’s Disease
Carolyn M. Sue · The University of Sydney
2023 · research · Novel PET Tracer Development Program
Development of a PET Tracer for Imaging of Neuroinflammation in Parkinson’s Disease
Enza Lacivita · University of Bari Aldo Moro
2023 · research · Accelerating Biological Understanding and Therapeutic Translation for Parkinson’s Disease Program
Examining a Novel GCase Activator in Neurons Derived from People with Parkinson’s Disease
Friederike Zunke · Universitätsklinikum Erlangen, Department Of Molecular Neurology
2023 · research · Research Grant
Chronos-PD: Using Proteomic Analysis to Detect Early Molecular Signatures of Parkinson’s Disease
Benoit Lehallier · Alkahest, Inc.
2023 · research · Accelerating Biological Understanding and Therapeutic Translation for Parkinson’s Disease Program
Developing Small Molecules to Enhance Autophagy and Clear Alpha-synuclein Aggregates as a Treatment for Parkinson’s Disease
John Blackwood · Samsara Therapeutics
2023 · research · Aligning Science Across Parkinson's
(Supplement) Exploring the Mechanisms by which Co-pathologies Drive Neuroinflammation and Progression in Parkinson’s Disease
Jeffrey H. Kordower · Rush University Medical Center
2023 · research · Accelerating Biological Understanding and Therapeutic Translation for Parkinson’s Disease Program
SUPPLEMENT | CMA as a Means to Counteract Alpha-synuclein Pathology in Non-human Primates”
Maria Xilouri · Biomedical Research Foundation of the Academy of Athens
2022 · research · Research Grant
Using a Systems-based Approach to Study the Molecular Processes Underlying Parkinson’s Disease: The Foundational Data Initiative
Andrew B. Singleton · National Institute on Aging
2022 · research · Fall 2021 RFP: Accelerating Early Proof-of-Concept Testing of Promising PD Therapies
Therapeutic Efficacy of IC 100 in Small Models
Nicholas A. Labella · Zyversa Therapeutics
2022 · research · Fall 2021 RFP: Expanding Biological Understanding of PD
Evaluation of Gene Products that Counteract the Action of LRRK2
Suzanne R. Pfeffer · Stanford University
2022 · research · Research Grant
Expanding Genetic Analyses in Parkinson’s Disease
Kelly N. H. Nudelman · Indiana University School of Medicine
2022 · research · Fall 2021 RFP: Accelerating Early Proof-of-Concept Testing of Promising PD Therapies
Phase 1b Trial to Assess the Safety and Efficacy of Dopamine Cell Transplants in Parkinson’s Disease Linked to Mutations in Parkin
Jeffrey H. Kordower · Rush University Medical Center
2022 · research · Alpha-synuclein Seed Amplification Assay Program
Quantifying Alpha-synuclein Aggregates Using Nanopore Sensor
Sébastien Balme · Université de Montpellier
2022 · research · Research Grant
Cognitive Assessment of Non-Human Primate Models of Parkinson's Disease
Jocelyne Bachevalier · Emory University
2022 · research · Research Grant
Shoring Up a Medical Chemistry Approach to Treating Parkinson’s Disease: The Bridge Initiative
Kalle Gehring · McGill University
2022 · research · Target Advancement Program
Assessing the Ability of Neuronal Modulators to Treat or Modify the Motor Symptoms of Parkinson’s Disease
Mark Stephen Moehle · University of Florida
2022 · research · Parkinson’s Pathway Molecular Data Analysis Program
Evaluating a Microbial Biomarker in Blood Samples for Parkinson’s Disease
Sarkis K. Mazmanian · California Institute of Technology
2022 · research · Parkinson’s Pathway Molecular Data Analysis Program
Resolution of Parkinson-associated Loci and Creation of Predictive Models Using Multi-omic Data Analyses
Laura Ibanez · Washington University in St. Louis
2022 · research · Summer 2022 RFP: Expanding Biological Understanding of Parkinson's Disease
Assessing Whether Cholesterol or Its Metabolites Increase the Risk of Developing Parkinson’s Disease
Gabriele Kaminski Schierle · University of Cambridge
2022 · research · Magnetic Resonance Imaging Biomarkers
Use of Novel Intestinal Imaging for Early Identification of Parkinson’s Disease and Assessment of Response to Therapies that Reduce Alpha-synuclein Accumulation
Anthony Schapira · University College London
2022 · research · Accelerating Early Proof-of-Concept Testing of Promising PD Therapies
Validation of RRx-001 as a Novel Disease-modifying Therapeutic for Parkinson's Disease
Tony R. Reid · Epicentrx, Inc At Epicentrx, Inc
2022 · research · Research Grant
Evaluation of Assessments Made by Digital Health Technology
Martijn L.T.M. Müller · Critical Path Institute
2022 · research · Parkinson’s Pathway Molecular Data Analysis Program
Using Data from the LEAPS Project to Improve the Accuracy of Assays that Measure Alpha-synuclein
Fábio Klamt · Universidade Federal do Rio Grande do Sul
2022 · research · Translational Pipeline Program
Development of a Nurr1 Activator as a Novel Therapeutic for Parkinson’s Disease
Deog Joong (Dj) Kim · Nurron Pharmaceuticals, Inc.